The U.S. Food and Drug Administration has granted premarket approval (PMA) to Deus Technologies of Rockville, MD, for its RapidScreen RS-2000 computer-aided diagnosis system for lung cancer screening.
RapidScreen RS-2000 digitizes and analyzes chest x-rays to identify areas that may have features associated with early-stage lung cancer. The system flags these suspicious areas for additional review by a radiologist.
By AuntMinnie.com staff writersJuly 13, 2001
Related Reading
CAD startup Deus seeks clearance for lung-cancer device, April 20, 2001
Deus nears approval for lung cancer detection unit, March 27, 2001
Copyright © 2001 AuntMinnie.com
